PERSPECTA

News from every angle

← Back to headlines

Tango Therapeutics Stock Soars on Pancreatic Cancer Trial Results

Tango Therapeutics (TNGX) shares surged following positive results from its pancreatic cancer trial.

9 Jun, 13:29 — 9 Jun, 13:29
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual84d ago

Tango Therapeutics (TNGX) Stock Soars on Pancreatic Cancer Trial Results

Read full article →

Related Stories

Mitsubishi Unveils All-New Fifth-Generation Pajero SUV

40m ago

Apple Names John Ternus as New CEO With $58 Million Compensation Package

42m ago

BP Appoints Ian Tyler as New Chairman Following Boardroom Changes

45m ago

Regional Tensions Surge as Iran Retaliates Against US Strikes in Middle East

45m ago